Article references (38 references )


  1. Minardi D, d'Anzeo Gianluca, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. Int J Gen Med. 2011; 4: 333-343. PubMed | Google Scholar

  2. Lienerrozos HJ. Urinary tract infections: management rationale for uncomplicated cystitis. ClinFamPrac. 2004; 6: 157-173.

  3. McLaughlin SP, Carson Culley. Urinary tract infections in women. Med Clin North Am. 2004; 88(2): 417-429. PubMed | Google Scholar

  4. Ebell MH. Treating adult women with suspected UTI. AmFam Physician. 2006; 73(2): 293-296. PubMed | Google Scholar

  5. Howes David, Kantor SS (2007). Urinary tract infection, male. Accessed May 17, 2007.

  6. Kamberi M, Tsutsumi Kimiko, Kotegawa T, Kawano K, Nakamura K, Niki Y, Nakano S. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. Antimicrob Agents Chemother. 1999; 43(3): 525-529. PubMed | Google Scholar

  7. Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med. 2002; 113(suppl 1A): 45S-54S. PubMed | Google Scholar

  8. Hooton TM, Bradley Suzanne, Cardenas DD, Colgan R, Geerlings SE, Rice JC et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from Infectious Diseases Society of America. Clin Infect Dis. 2010; 50(5): 625-663. PubMed | Google Scholar

  9. Fu Y, Zhang Wenli, Wang H, Zhao S, Chen Y, Meng F et al. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumonia and Escherichia coli. BMC Infect Dis. 2013; 13: 8. PubMed | Google Scholar

  10. King DE, Malone Robb, Lilley SH. New classification and update on the quinolone antibiotics. Am Fam Physician. 2000; 61(9): 2741-2748. PubMed | Google Scholar

  11. Acar Jean, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis. 1997; 24 (suppl 1): S67-73. PubMed | Google Scholar

  12. Stein GE, Havlichek Daniel. Newer oral antimicrobials for resistant respiratory tract pathogens: which show the most promise. Postgrad Med. 1998; 103(6): 67-70. PubMed | Google Scholar

  13. Lesho E, Waterman Paige, Chukwuma U, McAuliffe K, Neumann C, Julius MD, Crouch H, Chandrasekera R, English JF, Clifford RJ, Kester KE. The antimicrobial resistance monitoring and research (ARMoR) program: the department of defense's response to escalating antimicrobial resistance. Clin Infec Dis. 2014; 59(3): 390-397. PubMed | Google Scholar

  14. Onoh RC, Umero Odidika, Egwuatu VE, Eeonu PO, Onoh TJP. Antibiotics sensitivity patterns of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria. Infect Drug Resist. 2013; 6: 225-233. PubMed | Google Scholar

  15. Labi AK, Obeng-Nkrumah Noah, Addision NO, Donkor ES. Salmonella blood stream infections in a tertiary care setting in Ghana. BMC Infect Dis. 2015; 14: 3857. PubMed | Google Scholar

  16. Afriyie DK, Gyansa-Lutterodt Martha, Amponsah SK, Asare G, Wiredu V, Wormenor E et al. Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital. PAMJ. 2015; 22: 87. PubMed | Google Scholar

  17. Afriyie DK, Gyansa-Lutterodt Martha, Amponsah SK, Asare G, Wiredu V, Wormenor E et al A. In Vitro susceptibility of clinical uropathogens to Levofloxacin at the Ghana Police Hospital. Int J Pharm. 2017; 7(1): 22-28.

  18. Jellheden B, Norrby Ragnar, Sandberg T. Symptomatic urinary tract infection in women in primary health care: bacteriological, clinical and diagnostic aspects in relation to host response to infection. Scand J Prim Health Care. 1996; 14(2): 122-128. PubMed | Google Scholar

  19. WHO. World Health Organization's strategy to contain resistance to antimicrobial drugs. Rev Panam Salud Publica. 2001; 10(4): 284-294.

  20. WHO. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance, Geneva; 2014. Accessed April 27, 2014.

  21. Agbagwa OE, Ifeanacho Emeka. The prevalence of UTI pathogens in urine specimen obtained from a hospital in Rivers State Nigeria. J Microbiol Res. 2015; 5(5): 143-148. Google Scholar

  22. Johnson JR, Stamm Walter. Urinary Tract Infections in Women: diagnosis and treatment. An Int Med. 1989; 111(11): 109-117. PubMed | Google Scholar

  23. Stamm WE, Norrby Ragnar. Urinary tract infections; disease panora and challenges. J Infect Dis. 2001 Mar 1; 183 Suppl 1: S1-4. PubMed | Google Scholar

  24. Ani OC, Mgbechi Kelechukwa. Prevalence of urinary tract infections (UTI) in sexually active women of Abakaliki, Ebony State, Nigeria. Anim Res Int. 2008; 5(2): 876-887.

  25. Moore KN, Day Rene, Albers M. Pathogenesis of urinary tract infections: a review. J ClinNurs. 2002; 11(5): 568-574. PubMed | Google Scholar

  26. Newman MJ, Frimpong Enoch, Sampane-Donkor E, Opintan JA, Asamoah-Adu A. Resistance to antimicrobial drugs in Ghana. Infect Drug Resist. 2011; 4: 215-220. PubMed | Google Scholar

  27. Feglo PK, Narkwa P. Prevalence and antifungal susceptibility patterns of yeast isolates at the Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Br Microbiol Res J. 2012; 2(1): 10-22.

  28. Bonadio Mario, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001; 40(4): 439-444. PubMed | Google Scholar

  29. Antwi S, Bates Imelda, Baffoe-Bonnie B, Critchley J. Urine dipstick as a screening test for urinary tract infection. Ann Trop Paediatr. 2008; 28(2): 117-122. PubMed | Google Scholar

  30. Bosu WK, Acquah Samuel. Susceptibility of urinary tract bacteria to antibiotics in Cape Coast, Ghana. East Afr Med J. 1996; 73(7): 468-470. PubMed | Google Scholar

  31. Gyasi-Sarpong CK, Yenli Edwin, Idriss A, Arhin AA, Aboah K, Azorliade R, Boaitey YA, Annan AA. Bacterial urinary tract infections among males with lower urinary tract obstruction at Komfo Anokye Teaching Hospital, Kumasi, Ghana. Open Access J Urol. 2012; 2: 131-136.

  32. Almuzaini T, Choonara Imti, Sammons H. Substandard and counterfeit medicines: a systematice review of the literature. BMJ Open. 2013 Aug 17; 3(8): e002923 PubMed | Google Scholar

  33. Opintah J, Newman Mercy, Arhin RE, Donkor ES, Gyansa-Lutterodt M, Mills-Pappoe W. Laboratory based nationwide surveillance of antimicrobial resistance in Ghana. Infect Drug Resist. 2015; 8: 379-389. PubMed | Google Scholar

  34. Poppe C, Ayroud M, Ollis G, Chirino-Trejo M, Smart N, Quessy S, Michel P. Trends in antimicrobial resistance of Salmonella isolated from animals, foods of animal origin and the environment of animal production in Canada, 1994-1997. Microb Drug Resist. 2001; 7(2): 197-212. PubMed | Google Scholar

  35. Gupta A, Chauhan Bimal, Pethani J, Shah P. Fluoroquinolones resistance among uropathogens at the tertiary-care hospital, Ahmedabad. Int J Med Sci Public Health. 2016; 5(8): 1583-1587. Google Scholar

  36. Bernabe KJ, Langendorf Celine, Ford N, Ronat JB, Murphy RA. Antimicrobial resistance inWest Africa: a systematic review andmeta-analysis. Int J Antimicrob Agents. 2017; 50(5): 629-639. PubMed | Google Scholar

  37. Lautenbach E, Strom Brian, Nachamkin I et al. Longitudinal trends in fluoroquinolone resistance among enterobacteriaceae isolates form inpatients and outpatients, 1989-2000: Difference in the emergence and epidemiology of resistance across organisms. Clin Infect Dis. 2004; 38(5): 655-662. PubMed | Google Scholar

  38. Avgustin JA, Keber Rok, Zerjavic K, Orazem T, Grabnar M. Emergence of quinolone resistance mediating Gene acc(6')-Ib-cr in Extended-Spectrum β lactamase producing Klebsiella Isolates Collected in Slovenia between 2000 and 2005. Antimicrob Agents Chemother. 2007; 51(11): 4171-4173. PubMed | Google Scholar